НовостиBenzingaRBC Capital Maintains Outperform on Opus Genetics, Raises Price Target to $11 RBC Capital Maintains Outperform on Opus Genetics, Raises Price Target to $11 Benzinga 2026.11.11 15:24 (GMT+0) Открыть на Benzinga Другие новости